Ascension's PyroCarbon foot implant:
This article was originally published in Clinica
Executive Summary
Ascension Orthopedics has received US FDA 510(k) approval to sell its first PyroCarbon implant for use in the lower extremities. The PyroSphere device is designed for the fourth and fifth tarsometatarsal joints in people suffering from the debilitating effects of arthritis in the foot. The Austin, Texas firm noted that it has expanded its product platforms to include arthroplasty, trauma and tissue regeneration. It currently offers over 10 arthroplasty products, a complete elbow trauma set and a tissue regeneration portfolio.
You may also be interested in...
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.